NCT06305702已完成不适用
Multicenter Real-world Clinical Study of Inetetamab-based Therapy in HER2-positive Metastatic Breast Cancer
Liaoning Tumor Hospital & Institute1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Progression Free Survival(PFS)
研究概览
简要总结
A multicenter real-world study was conducted to gather clinicopathological data from patients with HER2-positive metastatic breast cancer who were treated with inetetamab between 2022 and 2023. The study aimed to estimate the progression-free survival (PFS), objective response rate (ORR), disease control rate (DCR), and adverse events (AEs) associated with inetetamab therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •An age of at least 18 years or older
- •Pathologically diagnosed with HER2-positive recurrent or metastatic breast cancer
- •Having at least one measurable lesion as defined
- •Receiving inetetamab-based therapy in the recurrent or metastatic stage
- •Having traceable medical history records
排除标准
- •Pregnant or lactating women
- •Patients with other conditions deemed unsuitable for participating in this study by the researcher
结局指标
主要结局
Progression Free Survival(PFS)
时间窗: 12 months
次要结局
- objective response rate (ORR)(12 months)
- Adverse events (AEs)(12 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric CancerAdvanced Gastric CancerNCT06767449Yonsei University80
Unknown
不适用
Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast CancerAdvanced HR+ HER2 Negative Breast CarcinomaNCT05295043Tianjin Medical University Cancer Institute and Hospital500
已完成
不适用
MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National RegistryMyelodysplastic SyndromeNCT01347944Celgene149
撤回
不适用
Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand EczemaChronic Hand EczemaNCT05545215Pierre Fabre Medicament
已完成
早期 1 期
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveAsthmaNCT01274507Janssen Research & Development, LLC328